Cargando…

Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis

Detalles Bibliográficos
Autores principales:	Singh, Manish, Cugati, Goutham, Singh, Pratibha, Singh, Ajai Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178957/ https://www.ncbi.nlm.nih.gov/pubmed/21966171 http://dx.doi.org/10.4103/0975-7406.84467

Ejemplares similares

Programmable morphine pump (an intrathecal drug delivery system) – A promising option for pain relief and palliation in cancer patients
por: Singh, Manish, et al.
Publicado: (2012)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

Limited unilateral partial laminectomy and lateral dural incision: One of the best approaches for spinal meningioma in selected cases
por: Singh, Manish, et al.
Publicado: (2012)

Effect of epilepsy on female fertility and reproductive abnormalities
por: Singh, Pratibha, et al.
Publicado: (2011)

Hyperprolactinemia: An often missed cause of male infertility
por: Singh, Pratibha, et al.
Publicado: (2011)

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
por: Singh, Pratibha, et al.
Publicado: (2011)

A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis
por: Yan, Ning, et al.
Publicado: (2015)

Primary spinal epidural lymphomas
por: Cugati, Goutham, et al.
Publicado: (2011)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

The US Food and Drug Administration's tentative approval process and the global fight against HIV
por: Chahal, Harinder Singh, et al.
Publicado: (2017)

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021
por: Monge, Andrea N., et al.
Publicado: (2022)

Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals
por: Kaplan, Robert M., et al.
Publicado: (2023)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020
por: Kayki-Mutlu, Gizem, et al.
Publicado: (2021)

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
por: Kayki-Mutlu, Gizem, et al.
Publicado: (2022)

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
por: Kayki-Mutlu, Gizem, et al.
Publicado: (2023)

Time for the US food and drug administration approval of condoms for anal intercourse
por: Nguyen, Brian T., et al.
Publicado: (2019)

Food and Drug Administration approvals in phase 3 Cancer clinical trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
por: Eadie, Ashley L., et al.
Publicado: (2021)

Hand Schuller Christian disease
por: Cugati, Goutham, et al.
Publicado: (2011)

Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
por: Chabner, Bruce A.
Publicado: (2017)

Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
por: Surnar, Bapurao, et al.
Publicado: (2020)

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs
por: Stein, Cy, et al.
Publicado: (2016)

Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations
por: Jiang, Di Maria, et al.
Publicado: (2019)

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs
por: Schuck, Robert N., et al.
Publicado: (2019)

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)

Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)

Efficacy End Points and Dose Analysis of Food and Drug Administration-Approved Novel Drugs in 2020
por: Tang, Albert
Publicado: (2022)

Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
por: Kayki-Mutlu, Gizem, et al.
Publicado: (2022)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021
por: Gupta, Ravi, et al.
Publicado: (2022)

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations
por: Zuabi, Nadia, et al.
Publicado: (2016)

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
por: Liang, Fei, et al.
Publicado: (2020)

Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review
por: Bonet Olivencia, Samuel, et al.
Publicado: (2021)

Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod
por: Gilbert-Girard, Shella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_79s580fac39mrcdq7713288n3f